Results 81 to 90 of about 2,597,047 (329)

Pharmacogenetics of ophthalmic topical β-blockers [PDF]

open access: yes, 2008
Glaucoma is the second leading cause of blindness worldwide. The primary glaucoma risk factor is elevated intraocular pressure. Topical β-blockers are affordable and widely used to lower intraocular pressure.
McCarty, Catherine A.   +4 more
core   +1 more source

Starting From Scratch: A White Woman's Journey to Build a Teaching Center Rooted in Adult Learning and Feminist Theories at an HBCU

open access: yesNew Directions for Adult and Continuing Education, EarlyView.
ABSTRACT This autobiographical article recounts a White woman's efforts to establish a center for teaching and learning (CTL) in a large HBCU in the southern part of the United States. She describes the ways in which tenets of critical feminism, feminist pedagogies, and adult learning and development informed her approach to faculty development.
Audrey Dentith
wiley   +1 more source

Review and new therapeutic alternatives for the treatment of cutaneous Leishmaniasis [PDF]

open access: yes, 2014
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/63704Leishmaniasis comprises a group of diseases caused by protozoa of the genus Leishmania and has two basic clinical forms, visceral Leishmaniasis and cutaneous Leishmaniasis. The clinical
Pujol Brugués, Alba   +1 more
core  

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials [PDF]

open access: yes, 2013
BACKGROUND HIV-associated distal sensory polyneuropathy (HIV-DSP) is the most frequently reported neurologic complication associated with HIV infection.
Brew, Bruce J   +9 more
core   +1 more source

An Evaluation of the in vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration versus Oral Administration

open access: yesScientific Reports, 2017
Nonporous silica nanoparticles (SiNPs) have potential as promising carriers for ophthalmic drugs. However, the in vivo safety of ocular topical SiNPs remains unclear.
Martha A. Kim   +6 more
semanticscholar   +1 more source

Employing Adult Learning Principles for Faculty Development of Equity Focused Teaching: Critical Reflections

open access: yesNew Directions for Adult and Continuing Education, EarlyView.
ABSTRACT This manuscript describes the intentional use of adult learning principles in creating three faculty development initiatives centering on equity‐based teaching. The authors reflected on the design and development process, facilitation and the perceived benefits and challenges.
Kayon Murray‐Johnson   +1 more
wiley   +1 more source

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose. [PDF]

open access: yes, 2018
Background:Topical high-precision piezo-print delivery of microdoses of latanoprost achieved significant IOP reduction consistent with the eyedropper effect but with a 75% reduced exposure to drugs and preservatives.
Ianchulev, Tsontcho   +5 more
core  

Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study [PDF]

open access: yes, 2019
Background: Dry eye disease (DED) affects more than 14% of the elderly population causing decrease of quality of life, high costs and vision impairment.
Allegretti, M.   +7 more
core   +1 more source

Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The myokine irisin, a recent positive mediator of exercise in the brain, shows neuroprotective functions against Alzheimer's disease (AD). The association between irisin and cognition has never been explored in a biologically defined cohort of patients.
Patrizia Pignataro   +12 more
wiley   +1 more source

Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases [PDF]

open access: yes, 2004
Fluticasone propionate - the first carbothioate corticosteroid - has been classified as a potent anti-inflammatory drug for dermatological use. It is available as 0.05% cream and 0.005% ointment formulations for the acute and maintenance treatment of ...
Atsuta J   +33 more
core   +1 more source

Home - About - Disclaimer - Privacy